Ingenol mebutate in low amounts for the treatment of actinic keratosis in Korean patients
Hyun Jae Joe, Byung Ho Oh Department of Dermatology, Keimyung University, College of Medicine, Daegu, Republic of Korea Background: Ingenol mebutate (IM), a novel agent for field therapy of actinic keratosis (AK), has a drawback of inducing local skin reactions (LSRs), which may cause discomfort in...
Main Authors: | Joe HJ, Oh BH |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-03-01
|
Series: | Clinical, Cosmetic and Investigational Dermatology |
Subjects: | |
Online Access: | https://www.dovepress.com/ingenol-mebutate-in-low-amounts-for-the-treatment-of-actinic-keratosis-peer-reviewed-article-CCID |
Similar Items
-
Ingenol mebutate treatment in actinic keratosis – clinical effectiveness and potential side effects
by: Aleksandra Lesiak, et al.
Published: (2019-08-01) -
Intense pustular reaction during treatment of actinic keratosis with ingenol mebutate
by: Dorota Jaśkiewicz-Nyckowska, et al.
Published: (2015-06-01) -
Ingenol mebutate: A novel topical drug for actinic keratosis
by: Suruchi Aditya, et al.
Published: (2013-01-01) -
Clinical utility of ingenol mebutate in the management of actinic keratosis: perspectives from clinical practice
by: Skroza N, et al.
Published: (2018-10-01) -
Improved patient satisfaction using ingenol mebutate gel 0.015% for the treatment of facial actinic keratoses: a prospective pilot study
by: Emilio J, et al.
Published: (2016-04-01)